{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:14:19Z","timestamp":1780539259058,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.jpsychires.2008.09.005","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T08:44:50Z","timestamp":1224146690000},"page":"600-606","source":"Crossref","is-referenced-by-count":50,"title":["Effects of DRD2\/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Yu-Chih","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaucer C.H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaw-Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sy-Ueng","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2008.09.005_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/6.4.577","article-title":"A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia","volume":"6","author":"Arinami","year":"1997","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib2","unstructured":"American Psychiatry Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC; 2000 [text review]."},{"key":"10.1016\/j.jpsychires.2008.09.005_bib3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.105.092155","article-title":"Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist","volume":"315","author":"Burstein","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2005.02.013","article-title":"Manual for the extrapyramidal symptom rating scale (ESRS)","volume":"76","author":"Chouinard","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1096-8628(200021)97:1<98::AID-AJMG12>3.0.CO;2-W","article-title":"Pharmacogenetics of schizophrenia","volume":"97","author":"Cichon","year":"2000","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib6","doi-asserted-by":"crossref","first-page":"26013","DOI":"10.1074\/jbc.271.42.26013","article-title":"Functional analysis of the human D2 dopamine receptor missense variants","volume":"271","author":"Cravchik","year":"1996","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/ddg055","article-title":"Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor","volume":"12","author":"Duan","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0920-9964(03)00220-2","article-title":"The 3\u2032 region of the DRD2 gene is involved in genetic susceptibility to schizophrenia","volume":"67","author":"Dubertret","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib9","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/2.12.2197-a","article-title":"PCR detection of the TaqA RFLP at the DRD2 locus","volume":"2","author":"Grandy","year":"1993","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/sj.mp.4001561","article-title":"C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo","volume":"9","author":"Hirvonen","year":"2004","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1006\/bbrc.1993.2404","article-title":"A structural polymorphism of human dopamine D2 receptor, D2 (Ser311\u2192Cys)","volume":"196","author":"Itokawa","year":"1993","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.mp.4000532","article-title":"Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers","volume":"4","author":"Jonsson","year":"1999","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib14","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1176\/appi.ajp.159.9.1593","article-title":"Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene","volume":"159","author":"Lane","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1461145704004389","article-title":"Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function","volume":"7","author":"Lane","year":"2004","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.schres.2004.08.020","article-title":"The C\/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia","volume":"73","author":"Lawford","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"Supplementum","key":"10.1016\/j.jpsychires.2008.09.005_bib17","first-page":"1","article-title":"The UKU side effect rating scale","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica."},{"key":"10.1016\/j.jpsychires.2008.09.005_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1176\/appi.ajp.161.5.780","article-title":"Pharmacogenetics of psychotropic drug response","volume":"161","author":"Malhotra","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1017\/S0033291799008636","article-title":"Duration of illness and structure of symptoms in schizophrenia","volume":"29","author":"Mojtabai","year":"1999","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.schres.2008.01.007","article-title":"Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population","volume":"100","author":"Monakhov","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/humu.20039","article-title":"Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1","volume":"23","author":"Neville","year":"2004","journal-title":"Human Mutation"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.mp.4000350","article-title":"The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers","volume":"3","author":"Pohjalainen","year":"1998","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib23","first-page":"1","article-title":"Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole","volume":"1","author":"Raja","year":"2006","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib24","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1176\/appi.ajp.161.7.1308","article-title":"Worsening schizoaffective disorder with aripiprazole","volume":"161","author":"Reeves","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1176\/appi.ajp.158.5.802","article-title":"Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene","volume":"158","author":"Schafer","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib26","first-page":"1045","article-title":"DRD2 Ser311\/Cys311 polymorphism in schizophrenia","volume":"343","author":"Shaikh","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00213-002-1084-4","article-title":"Clinical applications of pharmacogenetics in psychiatry","volume":"162","author":"Staddon","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-200006000-00007","article-title":"The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients","volume":"10","author":"Suzuki","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008571-199712000-00006","article-title":"D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele","volume":"7","author":"Thompson","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib30","first-page":"67","article-title":"Aripiprazole: an overview of a novel antipsychotic","volume":"17","author":"Uzun","year":"2005","journal-title":"Psychiatria Danubina"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2004.11.014","article-title":"Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients","volume":"376","author":"Wu","year":"2005","journal-title":"Neuroscience Letter"},{"key":"10.1016\/j.jpsychires.2008.09.005_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.tpj.6500211","article-title":"Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone","volume":"3","author":"Yamanouchi","year":"2003","journal-title":"The Pharmacogenomics Journal"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395608001891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395608001891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T03:51:53Z","timestamp":1545709913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395608001891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0022395608001891"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2008.09.005","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}